Healthcare Sector Stocks
The Healthcare sector has a total of 1053 stocks, with a combined market cap of $8.98 trillion, total revenue of $4.62 trillion and a weighted average PE ratio of 46.25.
Market Cap
8.98T
Revenue
4.62T
Profits
194.21B
PE Ratio
46.25
Profit Margin
4.20%
Dividend Yield
0.39%
1054 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 994.90B | -0.51% | 4,097,188 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 614.36B | 0.20% | 7,361,578 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 430.82B | -0.53% | 8,028,458 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 370.11B | -1.88% | 5,266,759 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 316.14B | 0.18% | 11,816,634 | 66.57B |
| 6 | NVS | Novartis AG | 292.53B | -0.26% | 1,706,549 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 244.84B | -1.49% | 8,095,274 | 61.37B |
| 8 | AMGN | Amgen Inc. | 210.50B | 2.94% | 3,622,725 | 38.10B |
| 9 | NVO | Novo Nordisk A/S | 209.62B | -5.97% | 47,477,486 | 50.34B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 208.81B | -1.62% | 1,941,856 | 46.34B |
| 11 | ABT | Abbott Laboratories | 182.49B | -1.55% | 8,156,902 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 167.92B | 3.13% | 10,124,480 | 30.46B |
| 13 | PFE | Pfizer Inc. | 144.83B | 1.52% | 62,188,535 | 63.70B |
| 14 | DHR | Danaher Corporation | 136.93B | -1.38% | 6,972,507 | 25.11B |
| 15 | BMY | Bristol-Myers Squibb Company | 134.59B | 0.64% | 23,288,641 | 49.19B |
| 16 | CVS | CVS Health Corporation | 133.23B | -0.90% | 7,229,147 | 405.62B |
| 17 | ISRG | Intuitive Surgical, Inc. | 130.10B | -1.90% | 3,938,806 | 11.03B |
| 18 | SYK | Stryker Corporation | 128.87B | -1.54% | 3,180,104 | 25.84B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 121.26B | 1.70% | 2,026,324 | 12.59B |
| 20 | MDT | Medtronic plc | 110.34B | -0.55% | 6,361,100 | 36.36B |
| 21 | GSK | GSK plc | 103.15B | 0.04% | 4,559,028 | 44.05B |
| 22 | SNY | Sanofi | 102.64B | -0.63% | 2,279,330 | 55.89B |
| 23 | MCK | McKesson Corporation | 97.22B | 0.40% | 1,089,459 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 86.76B | -1.45% | 1,318,771 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 81.98B | -1.25% | 1,438,031 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 75.96B | 0.19% | 804,667 | 15.53B |
| 27 | CI | The Cigna Group | 72.42B | -2.84% | 2,799,151 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 71.14B | 1.36% | 21,565,008 | 21.00B |
| 29 | COR | Cencora, Inc. | 59.59B | -0.68% | 2,454,362 | 328.68B |
| 30 | MDLN | Medline Inc. | 55.23B | 3.88% | 7,760,760 | 29.14B |
| 31 | CAH | Cardinal Health, Inc. | 54.70B | -0.87% | 2,578,995 | 250.74B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 53.57B | -1.60% | 5,910,580 | 28.42B |
| 33 | ARGX | argenx SE | 52.43B | 1.65% | 264,376 | 5.32B |
| 34 | EW | Edwards Lifesciences Corporation | 51.59B | 0.88% | 4,318,688 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 46.87B | -0.05% | 2,104,742 | 22.23B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 46.39B | 3.57% | 1,558,030 | 4.55B |
| 37 | HUM | Humana Inc. | 43.49B | -3.30% | 1,553,236 | 145.68B |
| 38 | HLN | Haleon plc | 42.37B | -0.20% | 9,146,954 | 14.80B |
| 39 | RVMD | Revolution Medicines, Inc. | 41.13B | 6.03% | 1,614,237 | - |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 40.12B | -0.09% | 4,924,473 | 17.32B |
| 41 | NTRA | Natera, Inc. | 39.41B | 1.79% | 1,922,867 | 2.50B |
| 42 | A | Agilent Technologies, Inc. | 39.31B | -0.43% | 1,623,761 | 7.23B |
| 43 | WAT | Waters Corporation | 38.89B | 5.69% | 1,999,943 | 4.64B |
| 44 | IQV | IQVIA Holdings Inc. | 37.56B | -2.21% | 1,493,878 | 16.98B |
| 45 | ONC | BeOne Medicines AG | 35.91B | 2.94% | 385,279 | 5.74B |
| 46 | ALC | Alcon Inc. | 34.47B | 1.11% | 1,656,234 | 10.63B |
| 47 | VEEV | Veeva Systems Inc. | 34.42B | 2.72% | 1,476,169 | 3.32B |
| 48 | RPRX | Royalty Pharma plc | 33.10B | 0.54% | 3,684,158 | 2.44B |
| 49 | DXCM | DexCom, Inc. | 32.81B | -0.42% | 6,123,940 | 4.97B |
| 50 | RMD | ResMed Inc. | 32.19B | 3.69% | 1,742,518 | 5.54B |
| 51 | ZTS | Zoetis Inc. | 31.88B | -1.37% | 7,620,385 | 9.53B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 31.74B | 0.76% | 3,427,249 | 21.27B |
| 53 | CNC | Centene Corporation | 31.65B | 0.49% | 6,025,518 | 180.30B |
| 54 | BIIB | Biogen Inc. | 30.80B | 3.29% | 1,205,636 | 10.03B |
| 55 | ILMN | Illumina, Inc. | 30.65B | 2.45% | 3,059,095 | 4.49B |
| 56 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.30B | -0.60% | 3,107,851 | 4.80B |
| 57 | MTD | Mettler-Toledo International Inc. | 28.79B | -0.55% | 178,096 | 4.13B |
| 58 | DGX | Quest Diagnostics Incorporated | 25.80B | 0.76% | 903,996 | 11.56B |
| 59 | PHG | Koninklijke Philips N.V. | 25.76B | 0.91% | 972,280 | 20.18B |
| 60 | LH | Labcorp Holdings Inc. | 25.27B | 1.60% | 748,496 | 14.35B |
| 61 | ROIV | Roivant Sciences Ltd. | 24.88B | 3.81% | 5,880,072 | 8.26M |
| 62 | WST | West Pharmaceutical Services, Inc. | 24.54B | 0.24% | 481,986 | 3.33B |
| 63 | INCY | Incyte Corporation | 24.45B | 1.83% | 2,077,575 | 5.82B |
| 64 | BNTX | BioNTech SE | 23.10B | -0.98% | 1,999,840 | 3.03B |
| 65 | MRNA | Moderna, Inc. | 22.75B | 3.36% | 3,999,813 | 2.23B |
| 66 | STE | STERIS plc | 22.69B | 0.09% | 910,723 | 5.94B |
| 67 | UTHR | United Therapeutics Corporation | 22.02B | 0.46% | 522,256 | 3.17B |
| 68 | GH | Guardant Health, Inc. | 21.44B | 0.60% | 2,185,372 | 1.18B |
| 69 | INSM | Insmed Incorporated | 21.40B | 0.30% | 4,290,652 | 819.56M |
| 70 | VTRS | Viatris Inc. | 20.61B | 0.40% | 8,888,502 | 14.56B |
| 71 | THC | Tenet Healthcare Corporation | 20.40B | 1.34% | 1,088,557 | 21.81B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 18.54B | -1.21% | 3,547,165 | 8.41B |
| 73 | GMAB | Genmab A/S | 17.76B | 1.19% | 1,320,542 | 3.90B |
| 74 | JAZZ | Jazz Pharmaceuticals plc | 16.98B | 3.99% | 1,895,112 | 4.60B |
| 75 | NBIX | Neurocrine Biosciences, Inc. | 16.88B | -0.10% | 1,197,253 | 3.37B |
| 76 | ASND | Ascendis Pharma A/S | 16.12B | 0.47% | 791,826 | 998.25M |
| 77 | MEDP | Medpace Holdings, Inc. | 16.05B | 0.31% | 227,917 | 2.78B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 16.04B | 2.64% | 1,686,928 | 579.96M |
| 79 | SOLV | Solventum Corporation | 15.23B | -0.15% | 1,808,585 | 8.26B |
| 80 | BAX | Baxter International Inc. | 14.66B | 0.89% | 10,209,423 | 11.47B |
| 81 | DVA | DaVita Inc. | 14.64B | -2.43% | 2,611,465 | 14.01B |
| 82 | COO | The Cooper Companies, Inc. | 14.57B | 0.62% | 1,970,035 | 4.23B |
| 83 | EXEL | Exelixis, Inc. | 14.08B | 1.71% | 2,729,798 | 2.38B |
| 84 | BTSG | BrightSpring Health Services, Inc. | 13.16B | 3.80% | 4,295,828 | 14.37B |
| 85 | ELAN | Elanco Animal Health Incorporated | 12.79B | -0.47% | 9,071,190 | 4.89B |
| 86 | PEN | Penumbra, Inc. | 12.77B | 0.37% | 363,249 | 1.50B |
| 87 | SNN | Smith & Nephew plc | 12.69B | -5.32% | 2,918,634 | 6.30B |
| 88 | FMS | Fresenius Medical Care AG | 12.65B | -4.95% | 1,672,508 | 22.20B |
| 89 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.62B | 4.16% | 2,031,048 | 669.50M |
| 90 | RVTY | Revvity, Inc. | 12.43B | -3.32% | 2,586,310 | 2.91B |
| 91 | ALGN | Align Technology, Inc. | 12.41B | 0.22% | 1,108,076 | 4.14B |
| 92 | ICLR | ICON Public Limited Company | 12.10B | -0.98% | 1,045,203 | 8.29B |
| 93 | CORT | Corcept Therapeutics Incorporated | 11.87B | -2.66% | 1,265,969 | 830.81M |
| 94 | BMRN | BioMarin Pharmaceutical Inc. | 11.74B | 1.20% | 1,239,096 | 3.24B |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.73B | 5.30% | 442,336 | 1.28B |
| 96 | PODD | Insulet Corporation | 11.55B | -1.70% | 1,748,785 | 2.90B |
| 97 | CRL | Charles River Laboratories International, Inc. | 11.28B | 1.41% | 1,146,545 | 4.03B |
| 98 | TECH | Bio-Techne Corporation | 11.23B | -0.07% | 3,039,601 | 1.21B |
| 99 | GMED | Globus Medical, Inc. | 11.06B | 0.06% | 1,206,636 | 3.10B |
| 100 | SMMT | Summit Therapeutics Inc. | 10.98B | 5.44% | 3,999,910 | - |
| 101 | EHC | Encompass Health Corporation | 10.96B | -1.75% | 1,094,519 | 6.07B |
| 102 | AXSM | Axsome Therapeutics, Inc. | 10.92B | 0.54% | 473,473 | 708.24M |
| 103 | ABVX | ABIVAX Société Anonyme | 10.79B | 0.33% | 634,794 | 5.67M |
| 104 | CYTK | Cytokinetics, Incorporated | 10.67B | 2.83% | 2,447,470 | 105.82M |
| 105 | ENSG | The Ensign Group, Inc. | 10.18B | -0.62% | 438,102 | 5.49B |
| 106 | RDY | Dr. Reddy's Laboratories Limited | 10.16B | 0.25% | 2,757,736 | 3.50B |
| 107 | UHS | Universal Health Services, Inc. | 10.16B | -0.69% | 733,735 | 18.11B |
| 108 | APGE | Apogee Therapeutics, Inc. | 10.07B | 0.06% | 2,377,912 | - |
| 109 | GKOS | Glaukos Corporation | 10.05B | -0.20% | 799,716 | 612.84M |
| 110 | HSIC | Henry Schein, Inc. | 9.97B | 3.01% | 3,325,838 | 13.60B |
| 111 | MOH | Molina Healthcare, Inc. | 9.97B | -1.75% | 582,998 | 42.47B |
| 112 | HALO | Halozyme Therapeutics, Inc. | 9.87B | 1.17% | 1,475,930 | 1.51B |
| 113 | KRYS | Krystal Biotech, Inc. | 9.61B | 3.90% | 534,611 | 440.48M |
| 114 | AVTR | Avantor, Inc. | 9.25B | 0.07% | 11,823,469 | 6.56B |
| 115 | SYRE | Spyre Therapeutics, Inc. | 9.23B | 10.54% | 831,889 | - |
| 116 | IONS | Ionis Pharmaceuticals, Inc. | 9.15B | 1.06% | 2,688,207 | 874.09M |
| 117 | OSCR | Oscar Health, Inc. | 9.15B | -1.17% | 3,068,246 | 13.30B |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 8.91B | -0.55% | 274,325 | 2.59B |
| 119 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.89B | 0.12% | 2,725,848 | 42.16M |
| 120 | HQY | HealthEquity, Inc. | 8.78B | 0.58% | 757,136 | 1.34B |
| 121 | QGEN | Qiagen N.V. | 8.75B | - | 3,362,001 | 2.10B |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 8.73B | 2.67% | 634,666 | 74.06M |
| 123 | ATR | AptarGroup, Inc. | 8.66B | -0.43% | 511,877 | 3.93B |
| 124 | PRAX | Praxis Precision Medicines, Inc. | 8.64B | 1.49% | 301,894 | 7.46M |
| 125 | KYMR | Kymera Therapeutics, Inc. | 8.59B | 4.07% | 601,334 | 51.48M |
| 126 | TEM | Tempus AI, Inc. | 8.49B | 2.17% | 4,188,322 | 1.43B |
| 127 | RGEN | Repligen Corporation | 8.45B | 1.85% | 1,196,052 | 785.10M |
| 128 | ALKS | Alkermes plc | 8.33B | 0.28% | 1,430,841 | 1.67B |
| 129 | IMVT | Immunovant, Inc. | 8.12B | 2.21% | 990,612 | - |
| 130 | PCVX | Vaxcyte, Inc. | 7.90B | 2.17% | 868,122 | - |
| 131 | LQDA | Liquidia Corporation | 7.86B | 5.40% | 1,111,585 | 288.07M |
| 132 | BRKR | Bruker Corporation | 7.66B | -21.79% | 8,880,722 | 3.50B |
| 133 | HIMS | Hims & Hers Health, Inc. | 7.44B | 4.35% | 11,425,552 | 2.37B |
| 134 | COGT | Cogent Biosciences, Inc. | 7.32B | 10.24% | 4,748,565 | - |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.28B | 2.92% | 1,643,705 | 239.92M |
| 136 | IBRX | ImmunityBio, Inc. | 7.28B | -2.80% | 19,006,776 | 165.79M |
| 137 | PACS | PACS Group, Inc. | 7.09B | 0.70% | 1,279,727 | 5.55B |
| 138 | GRFS | Grifols, S.A. | 7.03B | 2.67% | 632,916 | 8.48B |
| 139 | CHE | Chemed Corporation | 7.02B | -0.16% | 247,676 | 2.60B |
| 140 | TGTX | TG Therapeutics, Inc. | 6.91B | 5.56% | 2,865,349 | 799.54M |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.58B | -0.08% | 4,502,411 | 1.55B |
| 142 | BLLN | BillionToOne, Inc. | 6.54B | 3.59% | 657,158 | 354.54M |
| 143 | ERAS | Erasca, Inc. | 6.38B | 3.03% | 4,759,030 | - |
| 144 | MIRM | Mirum Pharmaceuticals, Inc. | 6.36B | -0.25% | 591,577 | 569.61M |
| 145 | CGON | CG Oncology, Inc. | 6.30B | 3.25% | 883,009 | 5.07M |
| 146 | TWST | Twist Bioscience Corporation | 6.24B | -1.60% | 1,245,668 | 431.80M |
| 147 | TFX | Teleflex Incorporated | 6.20B | 0.30% | 605,105 | 2.13B |
| 148 | XENE | Xenon Pharmaceuticals Inc. | 6.19B | 2.81% | 639,245 | 7.50M |
| 149 | BLTE | Belite Bio, Inc | 6.19B | 1.60% | 105,519 | - |
| 150 | HNGE | Hinge Health, Inc. | 6.15B | 2.28% | 2,570,495 | 720.06M |
| 151 | TXG | 10x Genomics, Inc. | 6.08B | 1.81% | 2,653,550 | 638.78M |
| 152 | DNTH | Dianthus Therapeutics, Inc. | 6.04B | 4.13% | 636,619 | 1.90M |
| 153 | LGND | Ligand Pharmaceuticals Incorporated | 5.96B | 3.00% | 329,154 | 274.48M |
| 154 | BLCO | Bausch + Lomb Corporation | 5.96B | -0.54% | 319,539 | 5.32B |
| 155 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.93B | 3.51% | 661,696 | 840.85M |
| 156 | ORKA | Oruka Therapeutics, Inc. | 5.92B | 3.52% | 621,227 | - |
| 157 | AMRX | Amneal Pharmaceuticals, Inc. | 5.90B | -1.96% | 2,127,283 | 3.12B |
| 158 | PTCT | PTC Therapeutics, Inc. | 5.77B | 1.44% | 1,420,924 | 1.01B |
| 159 | SRRK | Scholar Rock Holding Corporation | 5.73B | 4.23% | 767,360 | - |
| 160 | DFTX | Definium Therapeutics, Inc. | 5.62B | 1.27% | 1,861,957 | - |
| 161 | RDNT | RadNet, Inc. | 5.44B | 3.62% | 1,598,701 | 2.14B |
| 162 | STVN | Stevanato Group S.p.A. | 5.36B | -4.57% | 1,022,963 | 1.40B |
| 163 | MMED | MiniMed Group, Inc. | 5.33B | -0.58% | 1,044,967 | 3.10B |
| 164 | CRSP | CRISPR Therapeutics AG | 5.23B | 7.06% | 2,142,950 | 13.39M |
| 165 | TVTX | Travere Therapeutics, Inc. | 5.21B | 1.89% | 2,464,273 | 591.33M |
| 166 | SHC | Sotera Health Company | 5.16B | 0.67% | 2,090,009 | 1.19B |
| 167 | MMSI | Merit Medical Systems, Inc. | 5.12B | 0.34% | 1,450,305 | 1.58B |
| 168 | DYN | Dyne Therapeutics, Inc. | 4.85B | 2.89% | 2,774,190 | - |
| 169 | EWTX | Edgewise Therapeutics, Inc. | 4.81B | 16.48% | 4,187,480 | - |
| 170 | LIVN | LivaNova PLC | 4.69B | 3.47% | 1,284,860 | 1.43B |
| 171 | ACAD | ACADIA Pharmaceuticals Inc. | 4.65B | 6.01% | 2,440,366 | 1.14B |
| 172 | PBLS | Parabilis Medicines, Inc. | 4.57B | 5.71% | 357,078 | - |
| 173 | WAY | Waystar Holding Corp. | 4.56B | 4.90% | 3,428,643 | 1.21B |
| 174 | CAI | Caris Life Sciences, Inc. | 4.55B | -1.35% | 4,844,422 | 907.29M |
| 175 | NVST | Envista Holdings Corporation | 4.55B | 2.16% | 3,180,176 | 2.81B |
| 176 | CELC | Celcuity Inc. | 4.51B | 5.44% | 713,874 | - |
| 177 | MANE | Veradermics, Incorporated | 4.48B | 5.29% | 1,702,714 | - |
| 178 | INDV | Indivior Pharmaceuticals, Inc. | 4.31B | -2.33% | 7,154,802 | 1.33B |
| 179 | ICUI | ICU Medical, Inc. | 4.30B | -0.57% | 320,758 | 2.16B |
| 180 | ELVN | Enliven Therapeutics, Inc. | 4.27B | 5.29% | 2,527,882 | - |
| 181 | RLAY | Relay Therapeutics, Inc. | 4.26B | 4.05% | 2,054,378 | 10.68M |
| 182 | TNGX | Tango Therapeutics, Inc. | 4.25B | 7.90% | 1,869,894 | 56.99M |
| 183 | ITGR | Integer Holdings Corporation | 4.25B | 0.48% | 3,692,875 | 1.84B |
| 184 | IRTC | iRhythm Holdings, Inc. | 4.18B | 1.98% | 636,261 | 787.85M |
| 185 | CON | Concentra Group Holdings Parent, Inc. | 3.98B | -1.83% | 741,444 | 2.23B |
| 186 | LFST | LifeStance Health Group, Inc. | 3.98B | -2.66% | 3,584,853 | 1.49B |
| 187 | DOCS | Doximity, Inc. | 3.93B | 1.06% | 2,743,486 | 644.86M |
| 188 | ADPT | Adaptive Biotechnologies Corporation | 3.90B | 6.23% | 3,291,439 | 308.08M |
| 189 | HAE | Haemonetics Corporation | 3.88B | -1.62% | 1,272,633 | 1.33B |
| 190 | VKTX | Viking Therapeutics, Inc. | 3.84B | 1.01% | 1,700,844 | - |
| 191 | DNLI | Denali Therapeutics Inc. | 3.84B | 4.41% | 993,493 | - |
| 192 | VCYT | Veracyte, Inc. | 3.73B | 3.48% | 1,987,096 | 561.90M |
| 193 | LEGN | Legend Biotech Corporation | 3.70B | 0.63% | 2,565,828 | 1.14B |
| 194 | WRBY | Warby Parker Inc. | 3.67B | 5.80% | 3,145,316 | 890.57M |
| 195 | RCUS | Arcus Biosciences, Inc. | 3.62B | 4.27% | 845,207 | 236.00M |
| 196 | OGN | Organon & Co. | 3.56B | - | 1,610,741 | 6.13B |
| 197 | OPCH | Option Care Health, Inc. | 3.55B | -0.04% | 2,510,849 | 5.69B |
| 198 | GPCR | Structure Therapeutics Inc. | 3.53B | 2.65% | 876,742 | - |
| 199 | ALMS | Alumis Inc. | 3.46B | 3.83% | 754,351 | 8.40M |
| 200 | TLX | Telix Pharmaceuticals Limited | 3.44B | 2.69% | 116,831 | 803.79M |
| 201 | IDYA | IDEAYA Biosciences, Inc. | 3.43B | 2.01% | 1,250,309 | 234.13M |
| 202 | BKD | Brookdale Senior Living Inc. | 3.40B | -0.97% | 5,597,281 | 3.00B |
| 203 | MBX | MBX Biosciences, Inc. | 3.37B | 9.77% | 695,953 | - |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 3.26B | 0.35% | 1,939,067 | 415.62M |
| 205 | NHC | National HealthCare Corporation | 3.25B | -6.54% | 166,851 | 1.53B |
| 206 | NAMS | NewAmsterdam Pharma Company N.V. | 3.22B | 0.22% | 1,080,328 | 22.57M |
| 207 | GRAL | GRAIL, Inc. | 3.12B | 3.46% | 532,565 | 156.12M |
| 208 | CLDX | Celldex Therapeutics, Inc. | 3.07B | 3.61% | 1,027,383 | 865.00K |
| 209 | QURE | uniQure N.V. | 3.03B | -0.86% | 1,287,329 | 18.67M |
| 210 | PRVA | Privia Health Group, Inc. | 3.00B | - | 1,125,880 | 2.25B |
| 211 | RGC | Regencell Bioscience Holdings Limited | 3.00B | -1.31% | 231,890 | - |
| 212 | IRON | Disc Medicine, Inc. | 2.99B | 1.95% | 380,026 | - |
| 213 | ACHC | Acadia Healthcare Company, Inc. | 2.95B | 3.53% | 1,814,819 | 3.37B |
| 214 | XRAY | DENTSPLY SIRONA Inc. | 2.86B | 0.99% | 4,298,768 | 3.68B |
| 215 | IMNM | Immunome, Inc. | 2.84B | 8.91% | 1,801,989 | 4.02M |
| 216 | BEAM | Beam Therapeutics Inc. | 2.82B | 9.42% | 2,151,053 | 156.04M |
| 217 | ALHC | Alignment Healthcare, Inc. | 2.80B | -7.14% | 12,517,737 | 4.58B |
| 218 | TMDX | TransMedics Group, Inc. | 2.79B | -0.98% | 1,634,694 | 668.47M |
| 219 | ESTA | Establishment Labs Holdings Inc. | 2.78B | 1.95% | 506,265 | 229.58M |
| 220 | KOD | Kodiak Sciences Inc. | 2.68B | 7.68% | 709,013 | - |
| 221 | TRVI | Trevi Therapeutics, Inc. | 2.66B | 4.75% | 2,484,502 | - |
| 222 | ATAI | AtaiBeckley Inc. | 2.66B | - | 6,320,180 | 3.49M |
| 223 | PLSE | Pulse Biosciences, Inc. | 2.64B | 1.17% | 342,589 | 751.00K |
| 224 | TARS | Tarsus Pharmaceuticals, Inc. | 2.63B | -0.34% | 541,861 | 535.08M |
| 225 | UFPT | UFP Technologies, Inc. | 2.59B | 25.16% | 637,551 | 631.64M |
| 226 | NEOG | Neogen Corporation | 2.58B | -0.76% | 3,163,706 | 870.40M |
| 227 | GRDN | Guardian Pharmacy Services, Inc. | 2.57B | -0.69% | 201,005 | 1.46B |
| 228 | NRIX | Nurix Therapeutics, Inc. | 2.56B | 6.33% | 1,191,549 | 36.77M |
| 229 | RARE | Ultragenyx Pharmaceutical Inc. | 2.53B | 3.16% | 2,103,416 | 717.00M |
| 230 | SUPN | Supernus Pharmaceuticals, Inc. | 2.51B | -5.98% | 3,323,620 | 830.44M |
| 231 | AXGN | Axogen, Inc. | 2.47B | 0.50% | 1,125,157 | 251.17M |
| 232 | PGNY | Progyny, Inc. | 2.47B | -0.16% | 720,659 | 1.29B |
| 233 | PBH | Prestige Consumer Healthcare Inc. | 2.46B | 0.15% | 1,072,252 | 1.09B |
| 234 | NKTR | Nektar Therapeutics | 2.46B | 3.07% | 717,892 | 55.63M |
| 235 | CDNA | CareDx, Inc. | 2.44B | -1.59% | 1,619,668 | 458.09M |
| 236 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.43B | 8.43% | 3,426,192 | -665.00K |
| 237 | LMAT | LeMaitre Vascular, Inc. | 2.42B | 2.09% | 407,872 | 262.43M |
| 238 | BHC | Bausch Health Companies Inc. | 2.41B | -8.00% | 17,153,812 | 10.85B |
| 239 | VCEL | Vericel Corporation | 2.37B | 0.63% | 440,777 | 306.30M |
| 240 | PHVS | Pharvaris N.V. | 2.37B | 5.02% | 250,541 | - |
| 241 | HTFL | HeartFlow, Inc. | 2.35B | 1.94% | 615,794 | 191.42M |
| 242 | KLRA | Kailera Therapeutics, Inc. | 2.35B | 4.56% | 399,005 | - |
| 243 | BFLY | Butterfly Network, Inc. | 2.35B | 7.18% | 10,507,114 | 112.14M |
| 244 | MLYS | Mineralys Therapeutics, Inc. | 2.34B | 2.79% | 663,821 | - |
| 245 | PGEN | Precigen, Inc. | 2.33B | -1.21% | 8,015,238 | 85.72M |
| 246 | SLS | SELLAS Life Sciences Group, Inc. | 2.32B | 5.26% | 5,089,754 | - |
| 247 | VRDN | Viridian Therapeutics, Inc. | 2.30B | 7.92% | 2,168,696 | 70.92M |
| 248 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.29B | 2.38% | 2,920,912 | 885.72M |
| 249 | HRMY | Harmony Biosciences Holdings, Inc. | 2.26B | 8.93% | 1,991,432 | 959.90M |
| 250 | SION | Sionna Therapeutics, Inc. | 2.25B | 1.38% | 913,011 | - |
| 251 | CLOV | Clover Health Investments, Corp. | 2.25B | -1.39% | 3,660,985 | 2.21B |
| 252 | NUVB | Nuvation Bio Inc. | 2.24B | 4.55% | 4,652,386 | 143.05M |
| 253 | PVLA | Palvella Therapeutics, Inc. | 2.19B | 7.96% | 279,027 | - |
| 254 | COAG | Hemab Therapeutics Holdings, Inc. | 2.17B | 3.38% | 484,692 | - |
| 255 | VERA | Vera Therapeutics, Inc. | 2.15B | -7.07% | 5,136,555 | - |
| 256 | WGS | GeneDx Holdings Corp. | 2.11B | 4.48% | 2,659,417 | 454.43M |
| 257 | NEO | NeoGenomics, Inc. | 2.09B | 2.84% | 2,707,900 | 766.30M |
| 258 | ADUS | Addus HomeCare Corporation | 2.08B | -2.68% | 388,947 | 1.48B |
| 259 | ZLAB | Zai Lab Limited | 2.08B | 1.71% | 290,021 | 453.28M |
| 260 | BHVN | Biohaven Ltd. | 2.07B | 2.84% | 2,414,540 | - |
| 261 | ADMA | ADMA Biologics, Inc. | 2.07B | 1.95% | 2,820,371 | 509.86M |
| 262 | STOK | Stoke Therapeutics, Inc. | 2.04B | 7.14% | 1,319,907 | 27.59M |
| 263 | AVAH | Aveanna Healthcare Holdings Inc. | 2.04B | -2.60% | 1,814,503 | 2.52B |
| 264 | SGRY | Surgery Partners, Inc. | 2.03B | -2.55% | 1,568,479 | 3.34B |
| 265 | HCM | HUTCHMED (China) Limited | 2.02B | 0.17% | 12,660 | 549.12M |
| 266 | RAPP | Rapport Therapeutics, Inc. | 2.02B | 3.46% | 398,034 | 20.00M |
| 267 | NBTX | Nanobiotix S.A. | 2.00B | 1.62% | 91,603 | 38.27M |
| 268 | GHRS | GH Research PLC | 2.00B | 3.30% | 632,270 | - |
| 269 | ATRC | AtriCure, Inc. | 1.98B | 0.72% | 873,566 | 569.62M |
| 270 | ZBIO | Zenas BioPharma, Inc. | 1.98B | 0.93% | 378,123 | 10.00M |
| 271 | TSHA | Taysha Gene Therapies, Inc. | 1.98B | 7.27% | 3,701,942 | 7.47M |
| 272 | MD | Pediatrix Medical Group, Inc. | 1.96B | -5.87% | 1,545,066 | 1.95B |
| 273 | MESO | Mesoblast Limited | 1.95B | 2.28% | 119,306 | 65.38M |
| 274 | IOVA | Iovance Biotherapeutics, Inc. | 1.95B | 1.04% | 10,682,083 | 285.61M |
| 275 | URGN | UroGen Pharma Ltd. | 1.94B | 3.45% | 734,380 | 140.49M |
| 276 | TYRA | Tyra Biosciences, Inc. | 1.93B | 1.53% | 396,451 | - |
| 277 | AUPH | Aurinia Pharmaceuticals Inc. | 1.92B | 2.47% | 980,968 | 298.30M |
| 278 | NVCR | NovoCure Limited | 1.89B | 6.20% | 1,739,916 | 699.19M |
| 279 | AGIO | Agios Pharmaceuticals, Inc. | 1.89B | 3.47% | 1,046,548 | 98.34M |
| 280 | OCUL | Ocular Therapeutix, Inc. | 1.89B | 2.26% | 2,231,545 | 52.06M |
| 281 | ALMR | Alamar Biosciences, Inc. | 1.88B | 0.15% | 272,612 | 87.16M |
| 282 | FBRX | Forte Biosciences, Inc. | 1.87B | -0.07% | 1,058,780 | - |
| 283 | ABCL | AbCellera Biologics Inc. | 1.86B | 4.46% | 3,968,395 | 79.21M |
| 284 | INSP | Inspire Medical Systems, Inc. | 1.85B | 22.83% | 2,328,948 | 898.74M |
| 285 | DMRA | Damora Therapeutics, Inc. | 1.85B | 5.11% | 551,073 | - |
| 286 | GENB | Generate Biomedicines, Inc. | 1.83B | -0.42% | 304,056 | 30.30M |
| 287 | KARD | Kardigan, Inc. | 1.83B | 2.60% | 136,916 | - |
| 288 | SNDA | Sonida Senior Living, Inc. | 1.80B | -4.15% | 493,640 | 367.34M |
| 289 | ENOV | Enovis Corporation | 1.78B | -1.78% | 1,365,674 | 2.28B |
| 290 | LKFT | Lakefront Biotherapeutics NV | 1.76B | -1.08% | 331,483 | 1.20B |
| 291 | SEPN | Septerna, Inc. | 1.76B | 11.44% | 398,821 | 72.26M |
| 292 | RXRX | Recursion Pharmaceuticals, Inc. | 1.76B | 4.09% | 21,577,753 | 66.41M |
| 293 | SRPT | Sarepta Therapeutics, Inc. | 1.73B | 3.21% | 2,876,949 | 2.18B |
| 294 | BCAX | Bicara Therapeutics Inc. | 1.71B | 1.40% | 815,071 | - |
| 295 | FTRE | Fortrea Holdings Inc. | 1.71B | -5.02% | 2,323,586 | 2.68B |
| 296 | TRLV | Trulieve Cannabis Corp. | 1.71B | 3.37% | 713,948 | 1.17B |
| 297 | IMCR | Immunocore Holdings plc | 1.69B | 2.50% | 576,248 | 412.81M |
| 298 | SNDX | Syndax Pharmaceuticals, Inc. | 1.69B | -0.83% | 2,043,885 | 252.25M |
| 299 | OMCL | Omnicell, Inc. | 1.69B | -1.33% | 1,157,656 | 1.25B |
| 300 | ANIP | ANI Pharmaceuticals, Inc. | 1.68B | -1.07% | 289,465 | 923.71M |
| 301 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.66B | 0.16% | 1,608,554 | 204.73M |
| 302 | ANAB | AnaptysBio, Inc. | 1.63B | 2.74% | 417,427 | 232.39M |
| 303 | ZYME | Zymeworks Inc. | 1.63B | 4.49% | 355,676 | 81.26M |
| 304 | ASTH | Astrana Health, Inc. | 1.61B | -0.67% | 400,242 | 3.53B |
| 305 | TRAX | First Tracks Biotherapeutics, Inc. | 1.61B | -0.32% | 689,966 | - |
| 306 | CMPS | COMPASS Pathways plc | 1.59B | 4.89% | 2,369,462 | - |
| 307 | ATEC | Alphatec Holdings, Inc. | 1.59B | 1.97% | 4,381,982 | 815.05M |
| 308 | BLFS | BioLife Solutions, Inc. | 1.59B | 1.15% | 597,985 | 101.66M |
| 309 | HCSG | Healthcare Services Group, Inc. | 1.59B | -1.11% | 862,555 | 1.86B |
| 310 | NTLA | Intellia Therapeutics, Inc. | 1.58B | 5.11% | 4,339,794 | 66.09M |
| 311 | AGL | agilon health, inc. | 1.58B | 0.71% | 433,439 | 5.82B |
| 312 | VIR | Vir Biotechnology, Inc. | 1.55B | 3.03% | 1,708,584 | 65.50M |
| 313 | ARDT | Ardent Health, Inc. | 1.54B | - | 413,476 | 6.41B |
| 314 | INVA | Innoviva, Inc. | 1.54B | 0.43% | 564,637 | 420.69M |
| 315 | MAZE | Maze Therapeutics, Inc. | 1.53B | 1.02% | 367,352 | 20.00M |
| 316 | AAPG | Ascentage Pharma Group International | 1.52B | -0.71% | 5,538 | 82.08M |
| 317 | KMTS | Kestra Medical Technologies, Ltd. | 1.52B | 8.09% | 731,243 | 95.13M |
| 318 | CNMD | CONMED Corporation | 1.51B | -2.82% | 561,605 | 1.37B |
| 319 | PRGO | Perrigo Company plc | 1.49B | 0.94% | 2,860,674 | 4.18B |
| 320 | HROW | Harrow, Inc. | 1.48B | 1.89% | 368,335 | 268.68M |
| 321 | XERS | Xeris Biopharma Holdings, Inc. | 1.48B | 0.74% | 1,843,644 | 314.85M |
| 322 | PAHC | Phibro Animal Health Corporation | 1.48B | -1.51% | 188,304 | 1.50B |
| 323 | MLTX | MoonLake Immunotherapeutics | 1.48B | 3.05% | 793,214 | - |
| 324 | XNCR | Xencor, Inc. | 1.48B | 2.68% | 760,594 | 97.36M |
| 325 | INNV | InnovAge Holding Corp. | 1.47B | -3.38% | 285,200 | 949.17M |
| 326 | AVBP | ArriVent BioPharma, Inc. | 1.47B | 6.24% | 427,469 | - |
| 327 | ABSI | Absci Corporation | 1.44B | 6.94% | 1,983,191 | 1.84M |
| 328 | PSNL | Personalis, Inc. | 1.42B | 2.42% | 1,679,067 | 69.67M |
| 329 | ORIC | ORIC Pharmaceuticals, Inc. | 1.39B | 27.08% | 5,043,989 | - |
| 330 | IART | Integra LifeSciences Holdings Corporation | 1.39B | 0.11% | 748,495 | 1.65B |
| 331 | AZTA | Azenta, Inc. | 1.39B | 0.84% | 894,337 | 613.81M |
| 332 | TNDM | Tandem Diabetes Care, Inc. | 1.38B | 0.45% | 2,821,969 | 1.03B |
| 333 | SVRA | Savara Inc. | 1.37B | 1.50% | 1,361,574 | - |
| 334 | ALVO | Alvotech | 1.37B | 1.32% | 570,661 | 562.04M |
| 335 | AVLN | Avalyn Pharma Inc. | 1.36B | 7.82% | 176,667 | - |
| 336 | GLUE | Monte Rosa Therapeutics, Inc. | 1.36B | 4.55% | 2,821,583 | 42.95M |
| 337 | PNTG | The Pennant Group, Inc. | 1.34B | -3.91% | 551,220 | 1.02B |
| 338 | AORT | Artivion, Inc. | 1.31B | -2.07% | 572,932 | 458.69M |
| 339 | LBRX | LB Pharmaceuticals Inc | 1.29B | 5.04% | 563,720 | - |
| 340 | AMN | AMN Healthcare Services, Inc. | 1.29B | 0.76% | 997,185 | 3.42B |
| 341 | IMTX | Immatics N.V. | 1.28B | 3.99% | 442,263 | 43.00M |
| 342 | JBIO | Jade Biosciences, Inc. | 1.27B | 11.49% | 1,687,316 | - |
| 343 | MNKD | MannKind Corporation | 1.26B | 4.21% | 5,118,133 | 360.78M |
| 344 | AKTS | Aktis Oncology, Inc. | 1.26B | 2.74% | 299,214 | 8.28M |
| 345 | NVAX | Novavax, Inc. | 1.26B | 3.37% | 3,249,410 | 596.34M |
| 346 | ETON | Eton Pharmaceuticals, Inc. | 1.26B | 1.53% | 341,767 | 86.93M |
| 347 | ARDX | Ardelyx, Inc. | 1.24B | 0.60% | 3,130,088 | 427.68M |
| 348 | FRNM | Freenome, Inc. | 1.23B | -0.91% | 600,025 | 34.24M |
| 349 | INBX | Inhibrx Biosciences, Inc. | 1.23B | 0.98% | 217,677 | 1.30M |
| 350 | AHG | Akso Health Group | 1.22B | 7.22% | 2,033 | 13.83M |
| 351 | TDOC | Teladoc Health, Inc. | 1.22B | 0.45% | 6,270,060 | 2.49B |
| 352 | VOR | Vor Biopharma Inc. | 1.21B | 3.92% | 834,868 | - |
| 353 | STAA | STAAR Surgical Company | 1.20B | -0.90% | 1,387,282 | 290.38M |
| 354 | OMDA | Omada Health, Inc. | 1.20B | -1.61% | 888,429 | 283.30M |
| 355 | QDEL | QuidelOrtho Corporation | 1.20B | -0.73% | 1,123,625 | 2.66B |
| 356 | IRMD | IRADIMED CORPORATION | 1.19B | 1.71% | 227,287 | 86.34M |
| 357 | CERT | Certara, Inc. | 1.19B | -4.65% | 10,801,617 | 421.75M |
| 358 | WVE | Wave Life Sciences Ltd. | 1.18B | 4.53% | 2,261,633 | 65.37M |
| 359 | DRTS | Alpha Tau Medical Ltd. | 1.18B | 9.73% | 582,682 | - |
| 360 | CRVS | Corvus Pharmaceuticals, Inc. | 1.17B | 4.11% | 766,890 | - |
| 361 | SDGR | Schrödinger, Inc. | 1.17B | 2.42% | 971,004 | 254.91M |
| 362 | COLL | Collegium Pharmaceutical, Inc. | 1.16B | 0.42% | 438,600 | 796.33M |
| 363 | USPH | U.S. Physical Therapy, Inc. | 1.15B | -2.51% | 242,643 | 787.69M |
| 364 | SPTX | Seaport Therapeutics, Inc. | 1.15B | 3.78% | 89,902 | - |
| 365 | MGTX | MeiraGTx Holdings plc | 1.14B | 3.45% | 573,145 | 79.76M |
| 366 | GDRX | GoodRx Holdings, Inc. | 1.13B | 5.70% | 2,756,172 | 787.89M |
| 367 | BVS | Bioventus Inc. | 1.12B | -0.37% | 947,239 | 576.30M |
| 368 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.11B | 6.87% | 3,908,893 | 69.64M |
| 369 | ANRO | Alto Neuroscience, Inc. | 1.10B | 3.52% | 555,437 | - |
| 370 | LMRI | Lumexa Imaging Holdings, Inc. | 1.09B | 0.80% | 661,031 | 1.03B |
| 371 | PCRX | Pacira BioSciences, Inc. | 1.09B | 2.60% | 1,130,088 | 746.16M |
| 372 | NUTX | Nutex Health Inc. | 1.09B | 3.18% | 121,178 | 879.95M |
| 373 | CGEM | Cullinan Therapeutics, Inc. | 1.08B | 8.00% | 664,280 | - |
| 374 | CRON | Cronos Group Inc. | 1.05B | -0.71% | 1,401,532 | 159.54M |
| 375 | PRCT | PROCEPT BioRobotics Corporation | 1.04B | -0.54% | 3,732,992 | 337.34M |
| 376 | OLMA | Olema Pharmaceuticals, Inc. | 1.03B | 4.26% | 1,159,865 | - |
| 377 | APMD | Apnimed, Inc. | 1.02B | 2.84% | 298,425 | 120.15M |
| 378 | SANA | Sana Biotechnology, Inc. | 1.02B | 6.92% | 1,709,689 | - |
| 379 | IVA | Inventiva S.A. | 1.02B | 6.12% | 1,024,369 | 7.94M |
| 380 | REPL | Replimune Group, Inc. | 1.00B | 0.08% | 6,086,244 | - |
| 381 | AVTX | Avalo Therapeutics, Inc. | 980.29M | 2.66% | 1,157,455 | 59.00K |
| 382 | EYPT | EyePoint, Inc. | 978.43M | -6.04% | 2,929,693 | 7.61M |
| 383 | OPK | OPKO Health, Inc. | 977.69M | - | 3,709,127 | 587.90M |
| 384 | JANX | Janux Therapeutics, Inc. | 973.31M | 4.18% | 564,659 | 13.73M |
| 385 | GMRS | GMR Solutions Inc. | 971.40M | -3.85% | 247,100 | 5.83B |
| 386 | ODTX | Odyssey Therapeutics, Inc. | 955.65M | 10.09% | 135,416 | 1.06M |
| 387 | CSTL | Castle Biosciences, Inc. | 952.53M | 2.60% | 675,294 | 357.28M |
| 388 | OMER | Omeros Corporation | 936.54M | 3.03% | 1,645,946 | 9.89M |
| 389 | AHCO | AdaptHealth Corp. | 893.23M | -38.04% | 19,045,267 | 3.36B |
| 390 | INMD | InMode Ltd. | 883.48M | 0.13% | 359,183 | 374.64M |
| 391 | AMPH | Amphastar Pharmaceuticals, Inc. | 877.45M | -1.58% | 481,599 | 720.53M |
| 392 | TBPH | Theravance Biopharma, Inc. | 874.86M | 0.06% | 420,208 | 109.78M |
| 393 | GLAS | Glass House Brands Inc. | 874.26M | 0.10% | 220,061 | 177.68M |
| 394 | ANNX | Annexon, Inc. | 873.28M | 1.52% | 2,557,893 | - |
| 395 | ABUS | Arbutus Biopharma Corporation | 873.12M | 1.38% | 958,664 | 191.45M |
| 396 | HSTM | HealthStream, Inc. | 870.61M | 5.19% | 370,760 | 321.12M |
| 397 | TALK | Talkspace, Inc. | 862.69M | -1.15% | 3,604,667 | 238.37M |
| 398 | GERN | Geron Corporation | 859.64M | 4.69% | 13,464,407 | 196.12M |
| 399 | SLDB | Solid Biosciences Inc. | 848.64M | 7.48% | 921,231 | - |
| 400 | KURA | Kura Oncology, Inc. | 840.69M | 3.05% | 1,005,500 | 71.64M |
| 401 | ACRS | Aclaris Therapeutics, Inc. | 835.19M | 8.14% | 2,576,983 | 8.37M |
| 402 | DSGN | Design Therapeutics, Inc. | 826.08M | 3.45% | 273,481 | - |
| 403 | SIBN | SI-BONE, Inc. | 817.80M | -0.05% | 1,246,011 | 213.60M |
| 404 | AVR | Anteris Technologies Global Corp. | 806.93M | - | 1,272,653 | 1.85M |
| 405 | SGP | SpyGlass Pharma, Inc. | 806.08M | 6.31% | 93,541 | - |
| 406 | MNPR | Monopar Therapeutics Inc. | 793.54M | 6.11% | 215,091 | - |
| 407 | TENX | Tenax Therapeutics, Inc. | 791.64M | -3.56% | 2,253,386 | - |
| 408 | AURA | Aura Biosciences, Inc. | 788.64M | 1.56% | 277,467 | - |
| 409 | DBVT | DBV Technologies S.A. | 788.61M | 0.96% | 330,458 | 5.04M |
| 410 | CADL | Candel Therapeutics, Inc. | 770.07M | 4.37% | 1,072,751 | - |
| 411 | SSII | SS Innovations International, Inc. | 766.50M | -3.04% | 122,372 | 48.47M |
| 412 | DRUG | Bright Minds Biosciences Inc. | 762.47M | 4.84% | 167,418 | - |
| 413 | PHAR | Pharming Group N.V. | 737.37M | 4.48% | 10,503 | 366.48M |
| 414 | AGMB | AgomAb Therapeutics NV | 725.42M | 8.95% | 87,469 | - |
| 415 | OCS | Oculis Holding AG | 724.05M | 0.84% | 310,990 | 1.40M |
| 416 | CTMX | CytomX Therapeutics, Inc. | 722.77M | 4.73% | 2,437,022 | 35.54M |
| 417 | CLYM | Climb Bio, Inc. | 719.19M | 6.35% | 1,031,567 | - |
| 418 | RIGL | Rigel Pharmaceuticals, Inc. | 716.03M | 3.39% | 334,134 | 276.79M |
| 419 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 710.55M | 7.52% | 507,088 | - |
| 420 | IRWD | Ironwood Pharmaceuticals, Inc. | 709.48M | -2.49% | 5,768,302 | 361.51M |
| 421 | PHR | Phreesia, Inc. | 707.13M | 1.24% | 784,163 | 495.59M |
| 422 | EVO | Evotec SE | 705.43M | 0.52% | 16,148 | 859.03M |
| 423 | CBLL | CeriBell, Inc. | 702.70M | 1.15% | 326,808 | 95.07M |
| 424 | CBIO | Crescent Biopharma, Inc. | 701.08M | 10.15% | 258,791 | 11.88M |
| 425 | NGNE | Neurogene Inc. | 685.68M | 4.69% | 142,208 | 925.00K |
| 426 | GYRE | Gyre Therapeutics, Inc. | 685.66M | 0.65% | 63,211 | 117.05M |
| 427 | TCMD | Tactile Systems Technology, Inc. | 679.85M | 1.21% | 182,803 | 343.52M |
| 428 | PHAT | Phathom Pharmaceuticals, Inc. | 671.18M | -5.90% | 2,189,755 | 239.66M |
| 429 | ACHV | Achieve Life Sciences, Inc. | 664.20M | 2.37% | 1,243,049 | - |
| 430 | IMMX | Immix Biopharma, Inc. | 664.20M | 10.81% | 1,868,836 | - |
| 431 | FTH | Faeth Therapeutics, Inc. | 657.36M | -6.73% | 651,930 | - |
| 432 | ALLO | Allogene Therapeutics, Inc. | 655.79M | 3.26% | 4,997,357 | 22.00K |
| 433 | BBNX | Beta Bionics, Inc. | 655.50M | 9.14% | 3,341,423 | 119.01M |
| 434 | BWAY | BrainsWay Ltd. | 637.62M | -0.06% | 140,944 | 56.22M |
| 435 | RGNX | REGENXBIO Inc. | 635.54M | 3.41% | 968,718 | 87.82M |
| 436 | NVCT | Nuvectis Pharma, Inc. | 633.66M | -6.94% | 592,173 | - |
| 437 | TLRY | Tilray Brands, Inc. | 629.25M | - | 6,409,429 | 915.45M |
| 438 | ANGO | AngioDynamics, Inc. | 627.84M | 0.13% | 624,101 | 320.17M |
| 439 | MDXG | MiMedx Group, Inc. | 622.40M | - | 1,806,926 | 355.17M |
| 440 | ZVRA | Zevra Therapeutics, Inc. | 621.89M | 4.57% | 1,284,325 | 122.29M |
| 441 | DNA | Ginkgo Bioworks Holdings, Inc. | 612.09M | 4.81% | 1,065,000 | 151.40M |
| 442 | STTK | Shattuck Labs, Inc. | 607.31M | 8.64% | 1,445,790 | 1.00M |
| 443 | CTNM | Contineum Therapeutics, Inc. | 598.18M | -0.19% | 430,201 | - |
| 444 | ALT | Altimmune, Inc. | 597.04M | 2.33% | 8,162,984 | 36.00K |
| 445 | CRMD | CorMedix Inc. | 589.96M | -0.40% | 651,180 | 400.05M |
| 446 | ARVN | Arvinas, Inc. | 587.70M | 11.66% | 3,032,794 | 316.70M |
| 447 | MPLT | MapLight Therapeutics, Inc. | 586.77M | 3.11% | 847,437 | - |
| 448 | HELP | Cybin Inc. | 575.21M | 15.14% | 3,632,874 | - |
| 449 | SOPH | SOPHiA GENETICS SA | 573.84M | 20.21% | 1,627,393 | 86.17M |
| 450 | RLMD | Relmada Therapeutics, Inc. | 573.75M | 3.21% | 1,196,703 | - |
| 451 | CTKB | Cytek Biosciences, Inc. | 552.73M | -0.70% | 819,167 | 204.17M |
| 452 | TECX | Tectonic Therapeutic, Inc. | 550.41M | 4.48% | 145,906 | - |
| 453 | WEAV | Weave Communications, Inc. | 546.62M | 1.78% | 722,913 | 248.72M |
| 454 | ZURA | Zura Bio Limited | 540.54M | 3.08% | 702,657 | - |
| 455 | PRME | Prime Medicine, Inc. | 538.24M | 6.05% | 3,161,501 | 4.03M |
| 456 | ARTV | Artiva Biotherapeutics, Inc. | 537.87M | 2.88% | 411,205 | 251.00K |
| 457 | FDMT | 4D Molecular Therapeutics, Inc. | 536.35M | 1.68% | 478,301 | 88.24M |
| 458 | KIDS | OrthoPediatrics Corp. | 536.30M | 0.05% | 268,887 | 252.72M |
| 459 | SPRY | ARS Pharmaceuticals, Inc. | 528.29M | -2.56% | 1,931,419 | 98.99M |
| 460 | SLN | Silence Therapeutics plc | 527.60M | 4.59% | 518,578 | 839.00K |
| 461 | VREX | Varex Imaging Corporation | 521.35M | 3.78% | 397,462 | 857.50M |
| 462 | ANL | Adlai Nortye Ltd. | 520.00M | 0.08% | 179,343 | 5.00M |
| 463 | RZLT | Rezolute, Inc. | 519.20M | 1.22% | 2,541,342 | - |
| 464 | AUTL | Autolus Therapeutics plc | 518.98M | 7.14% | 4,209,870 | 92.62M |
| 465 | EIKN | Eikon Therapeutics, Inc. | 517.57M | 4.48% | 395,939 | - |
| 466 | STLN | Starling Oncology, Inc. | 516.91M | 0.78% | 1,075,005 | 545.76M |
| 467 | VSTM | Verastem, Inc. | 510.55M | 2.11% | 1,789,826 | 49.59M |
| 468 | FLGT | Fulgent Genetics, Inc. | 510.41M | 5.34% | 550,519 | 323.93M |
| 469 | ASMB | Assembly Biosciences, Inc. | 509.00M | 4.26% | 90,954 | 71.10M |
| 470 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 471 | BIOA | BioAge Labs, Inc. | 497.87M | 3.90% | 2,368,979 | 10.32M |
| 472 | SLBT | SL Science Holding Limited | 497.81M | -6.38% | 164,797 | 3.27M |
| 473 | SGMT | Sagimet Biosciences Inc. | 493.40M | 11.75% | 1,705,970 | - |
| 474 | OFIX | Orthofix Medical Inc. | 493.14M | -0.49% | 413,083 | 825.37M |
| 475 | SRTA | Strata Critical Medical, Inc. | 492.76M | 0.36% | 2,059,793 | 255.98M |
| 476 | PROK | ProKidney Corp. | 492.36M | 4.49% | 698,919 | 889.00K |
| 477 | VALN | Valneva SE | 484.44M | 1.38% | 6,462 | 180.25M |
| 478 | NPCE | NeuroPace, Inc. | 482.09M | 4.74% | 275,077 | 99.53M |
| 479 | QTTB | Q32 Bio Inc. | 480.84M | 6.49% | 728,090 | 53.74M |
| 480 | IKT | Inhibikase Therapeutics, Inc. | 476.83M | 10.41% | 1,255,013 | 1.00 |
| 481 | OVID | Ovid Therapeutics Inc. | 474.07M | 9.01% | 1,666,457 | 7.12M |
| 482 | KYTX | Kyverna Therapeutics, Inc. | 472.99M | 3.60% | 563,651 | - |
| 483 | EVMN | Evommune, Inc. | 472.20M | 13.11% | 878,638 | 10.00M |
| 484 | SI | Shoulder Innovations, Inc. | 470.55M | 1.39% | 178,861 | 53.89M |
| 485 | AQST | Aquestive Therapeutics, Inc. | 469.25M | -1.32% | 2,691,589 | 50.27M |
| 486 | DCTH | Delcath Systems, Inc. | 453.61M | 0.77% | 441,299 | 90.44M |
| 487 | CABA | Cabaletta Bio, Inc. | 451.66M | 2.97% | 2,710,071 | - |
| 488 | CTEV | Claritev Corporation | 450.06M | 8.69% | 68,128 | 978.76M |
| 489 | PRLD | Prelude Therapeutics Incorporated | 448.28M | 2.96% | 218,798 | 16.72M |
| 490 | PACB | Pacific Biosciences of California, Inc. | 447.27M | 1.41% | 6,396,543 | 160.03M |
| 491 | NNNN | Anbio Biotechnology | 445.50M | -4.69% | 67,896 | 8.65M |
| 492 | PRTA | Prothena Corporation plc | 444.48M | 1.92% | 329,912 | 57.94M |
| 493 | OCGN | Ocugen, Inc. | 443.46M | 4.80% | 6,551,201 | 4.47M |
| 494 | CERS | Cerus Corporation | 441.34M | 1.86% | 6,258,706 | 221.55M |
| 495 | NRC | NRC Health | 433.71M | 0.46% | 143,674 | 140.00M |
| 496 | BNTC | Benitec Biopharma Inc. | 430.12M | 3.05% | 64,827 | - |
| 497 | LRMR | Larimar Therapeutics, Inc. | 429.01M | 3.27% | 1,681,528 | - |
| 498 | STRO | Sutro Biopharma, Inc. | 425.36M | 2.27% | 147,821 | 99.61M |
| 499 | EDIT | Editas Medicine, Inc. | 425.09M | 4.53% | 1,559,623 | 38.69M |
| 500 | EPRX | Eupraxia Pharmaceuticals Inc. | 423.57M | 0.15% | 250,470 | - |